NASDAQ:HSIC

Henry Schein (HSIC) Stock Price, News & Analysis

Henry Schein logo
$84.96 -1.26 (-1.46%)
Closing price 04:00 PM Eastern
Extended Trading
$84.94 -0.02 (-0.02%)
As of 05:19 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

About Henry Schein Stock (NASDAQ:HSIC)

Advanced

Key Stats

Today's Range
$83.87
▼
$86.22
50-Day Range
$82.50
▼
$89.81
52-Week Range
$68.70
▼
$92.18
Volume
1.71 million shs
Average Volume
1.36 million shs
Market Capitalization
$9.39 billion
P/E Ratio
23.28
Dividend Yield
N/A
Price Target
$93.57
Consensus Rating
Moderate Buy

Company Overview

Henry Schein, Inc. is a global distributor of health care products and services, serving dental and medical practitioners, veterinary professionals, and other health care organizations. The company traces its roots to a pharmacy founded by Henry and Esther Schein in Queens, New York, in 1932.

Its offerings include medical and dental supplies, equipment, pharmaceuticals, vaccines, and diagnostic products. Henry Schein also provides practice-management software, technology solutions, and business services designed to help health care professionals manage their operations.

The company serves customers across North America and international markets, including Europe, Asia-Pacific, and other regions. Its customer base includes independent practices as well as clinics, laboratories, and institutional health care providers.

AI Generated. May Contain Errors.

Henry Schein Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
47th Percentile Overall Score

HSIC MarketRank™: 
2.327014846235 of 5 stars

Henry Schein scored higher than 47% of companies evaluated by MarketBeat, and ranked 575th out of 877 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Henry Schein has received a consensus rating of Moderate Buy. The company's average rating score is 2.50, and is based on no strong buy ratings, 8 buy ratings, 5 hold ratings, and 1 sell rating.

  • Upside Potential

    Henry Schein has a consensus price target of $93.57, representing about 10.2% upside from its current price of $84.90.

  • Amount of Analyst Coverage

    Henry Schein has only been the subject of 4 research reports in the past 90 days.

  • Read more about Henry Schein's stock forecast and price target.
  • Earnings Growth

    Earnings for Henry Schein are expected to grow by 7.57% in the coming year, from $5.55 to $5.97 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Henry Schein is 23.19, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 26.17.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Henry Schein is 23.19, which means that it is trading at a less expensive P/E ratio than the Healthcare sector average P/E ratio of about 34.34.

  • Price to Earnings Growth Ratio

    Henry Schein has a PEG Ratio of 1.51. PEG Ratios above 1 indicate that a company could be overvalued.

  • Price to Book Value per Share Ratio

    Henry Schein has a P/B Ratio of 2.56. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

  • Percentage of Shares Shorted

    8.54% of the float of Henry Schein has been sold short.
  • Short Interest Ratio / Days to Cover

    Henry Schein has a short interest ratio ("days to cover") of 8.3.
  • Change versus previous month

    Short interest in Henry Schein has recently increased by 3.95%, indicating that investor sentiment is decreasing.
  • Dividend Yield

    Henry Schein does not currently pay a dividend.

  • Dividend Growth

    Henry Schein does not have a long track record of dividend growth.

  • News Sentiment

    Henry Schein has a news sentiment score of 0.13. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.59 average news sentiment score of Healthcare companies.
  • News Coverage This Week

    MarketBeat has tracked 8 news articles for Henry Schein this week, compared to 6 articles on an average week.
  • Search Interest

    Only 1 people have searched for HSIC on MarketBeat in the last 30 days. This is a decrease of -50% compared to the previous 30 days.
  • MarketBeat Follows

    Only 1 people have added Henry Schein to their MarketBeat watchlist in the last 30 days. This is a decrease of 0% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Henry Schein insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    0.89% of the stock of Henry Schein is held by insiders.

  • Percentage Held by Institutions

    96.62% of the stock of Henry Schein is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about Henry Schein's insider trading history.
Receive HSIC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Henry Schein and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

HSIC Stock News Headlines

Henry Schein Lowers 2026 Non-GAAP EPS Outlook
A $247 tool for $7
Bill Poulos is offering his $247 Instant Scanner for $7 in the Black Friday sale. It's one payment for a full year, with no re-bills and nothing to install. The catch? He isn't trying to profit on the scanner itself. Poulos is betting that once you see it deliver the night's list, you'll want more of his work for years.tc pixel
Henry Schein Updates Presentation of Non-GAAP Financial Measures
See More Headlines

HSIC Stock Analysis - Frequently Asked Questions

Henry Schein's stock was trading at $75.58 at the start of the year. Since then, HSIC stock has increased by 12.3% and is now trading at $84.9030.

Henry Schein, Inc. (NASDAQ:HSIC) posted its earnings results on Tuesday, November, 3rd. The company reported $1.56 earnings per share for the quarter, topping analysts' consensus estimates of $1.36 by $0.20. The company's revenue was up 4.0% on a year-over-year basis.
Read the conference call transcript
.

Shares of Henry Schein split before market open on Friday, September 15th 2017.The 2-1 split was announced on Wednesday, August 16th 2017. The newly issued shares were payable to shareholders after the closing bell on Thursday, September 14th 2017. An investor that had 100 shares of stock prior to the split would have 200 shares after the split.

Henry Schein subsidiaries include these companies: Prism Medical Products LLC, Elite Computer Italia, Southern Anesthesia & Surgical, Marrodent, Dental Cremer, RxWorks, Dental Trey, and others.

Top institutional investors of Henry Schein include Gamco Investors INC. ET AL (0.33%), Gabelli Funds LLC (0.26%), Russell Investments Group Ltd. (0.16%) and Banyan Capital Management Inc. (0.09%). Insiders that own company stock include Stanley M Bergman, James P Breslawski, Michael S Ettinger, Thomas C Popeck, Mark E Mlotek, Lorelei Mcglynn, Bradford C Connett, Philip A Laskawy and Kurt P Kuehn.
View institutional ownership trends
.

Shares of HSIC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Henry Schein investors own include Alibaba Group (BABA), Walt Disney (DIS), Bristol Myers Squibb (BMY), CVS Health (CVS), Bank of America (BAC), Advanced Micro Devices (AMD) and Amgen (AMGN).

Company Calendar

Last Earnings
11/03/2026
Today
11/16/2026
Jefferies Global Healthcare Conference
11/17/2026
38th Annual Healthcare Conference
12/01/2026
Fiscal Year End
12/31/2026

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Industry
Healthcare Providers & Services
Sub-Industry
Healthcare Distributors
Current Symbol
NASDAQ:HSIC
CIK
1000228
Employees
25,000
Year Founded
1932

Price Target and Rating

High Price Target
$112.00
Low Price Target
$64.00
Potential Upside/Downside
+10.1%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.50
Research Coverage
14 Analysts

Profitability

EPS (Trailing Twelve Months)
$3.65
Trailing P/E Ratio
23.28
Forward P/E Ratio
14.23
P/E Growth
1.51
Net Income
$398 million
Net Margins
3.07%
Pretax Margin
4.22%
Return on Equity
16.39%
Return on Assets
5.58%

Debt

Debt-to-Equity Ratio
0.62
Current Ratio
1.33
Quick Ratio
0.76

Sales & Book Value

Annual Sales
$13.18 billion
Price / Sales
0.71
Cash Flow
$7.67 per share
Price / Cash Flow
11.08
Book Value
$33.12 per share
Price / Book
2.57

Miscellaneous

Outstanding Shares
110,540,000
Free Float
109,555,000
Market Cap
$9.39 billion
Optionable
Optionable
Beta
0.87

Social Links

The 7 Best High-Yield Dividend Stocks for 2027 Cover

Looking for higher dividend income in 2027? Discover seven high-yield dividend stocks with attractive payouts, proven dividend histories and growth potential.

Get This Free Report

This page (NASDAQ:HSIC) was last updated on 11/16/2026 by MarketBeat.com Staff.
From Our Partners